Detalles de la búsqueda
1.
Are you laughing with me or at me? Psychopathic traits and the ability to distinguish between affiliation and dominance laughter cues.
J Pers
; 90(4): 631-644, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714936
2.
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts.
Cancer Sci
; 111(2): 536-547, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31778267
3.
Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite.
Drug Metab Dispos
; 48(10): 873-885, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32665418
4.
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment.
Invest New Drugs
; 38(6): 1774-1783, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410080
5.
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.
J Neurooncol
; 146(1): 79-89, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31776899
6.
Cytochrome P450 induction response in tethered spheroids as a three-dimensional human hepatocyte in vitro model.
J Appl Toxicol
; 36(2): 320-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26201057
7.
4ß-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.
Drug Metab Dispos
; 42(5): 839-43, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24595680
8.
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia.
J Clin Lipidol
; 17(3): 392-400, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37164838
9.
Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation.
J Med Chem
; 65(13): 8713-8734, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790118
10.
New paradigm for expediting drug development in Asia.
Drug Discov Today
; 25(3): 491-496, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31926136
11.
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma.
Leukemia
; 33(12): 2924-2933, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092894
12.
In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401.
Eur J Drug Metab Pharmacokinet
; 44(5): 669-680, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31030415
13.
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer.
J Clin Oncol
; 36(31): 3101-3109, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30156984
14.
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.
Cancer Res
; 70(13): 5518-27, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20551065
Resultados
1 -
14
de 14
1
Próxima >
>>